{"id":235,"date":"2005-06-03T22:49:51","date_gmt":"2005-06-04T02:49:51","guid":{"rendered":"http:\/\/www.chrismclaren.com\/blog\/archives\/2005\/06\/03\/forget-investment-what-about-retail\/"},"modified":"2005-06-03T22:53:31","modified_gmt":"2005-06-04T02:53:31","slug":"forget-investment-what-about-retail","status":"publish","type":"post","link":"http:\/\/www.chrismclaren.com\/blog\/2005\/06\/03\/forget-investment-what-about-retail\/","title":{"rendered":"Forget Investment–what about retail?"},"content":{"rendered":"

And now, from the Pohl & Kornbluth<\/a> category, an article about a study of a drug that makes the recipients more prone to trusting people<\/a>:<\/p>\n

In the first experiment, they played a game in which an “investor” could choose to hand over to a “trustee” up to 12 units of money that are each equal to .40 Swiss franc, or about 32 cents. The trustee triples the investor’s money, then gets to decide how much of the proceeds to share.<\/p>\n

Of 29 subjects who got oxytocin, 45 percent invested the maximum amount of 12 monetary units and, in the researchers’ words, showed “maximal trust.” Only 21 percent had a lower trust level in which they invested less than 8 monetary units.<\/p><\/blockquote>\n

I can imagine people going a little distopian nuts on this–mists of this drug in the air at political rallies, etc., but the thing that really worries me is the potential retail aspect: malls full of this stuff, and the complete and utter eradication of the tiny little bit of sales resistance that I have.<\/p>\n","protected":false},"excerpt":{"rendered":"

And now, from the Pohl & Kornbluth category, an article about a study of a drug that makes the recipients more prone to trusting people: In the first experiment, they played a game in which an “investor” could choose to hand over to a “trustee” up to 12 units of money that are each equal to .40 Swiss franc, or… Read more →<\/a><\/p>\n","protected":false},"author":13,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[3],"tags":[],"class_list":["post-235","post","type-post","status-publish","format-standard","hentry","category-technology","xfolkentry"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p5UQvw-3N","_links":{"self":[{"href":"http:\/\/www.chrismclaren.com\/blog\/wp-json\/wp\/v2\/posts\/235","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/www.chrismclaren.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.chrismclaren.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.chrismclaren.com\/blog\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"http:\/\/www.chrismclaren.com\/blog\/wp-json\/wp\/v2\/comments?post=235"}],"version-history":[{"count":0,"href":"http:\/\/www.chrismclaren.com\/blog\/wp-json\/wp\/v2\/posts\/235\/revisions"}],"wp:attachment":[{"href":"http:\/\/www.chrismclaren.com\/blog\/wp-json\/wp\/v2\/media?parent=235"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.chrismclaren.com\/blog\/wp-json\/wp\/v2\/categories?post=235"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.chrismclaren.com\/blog\/wp-json\/wp\/v2\/tags?post=235"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}